Endocrine Abstracts

Background and aims: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Osteoporosis are two silent prevalent metabolic conditions. MASLD involves fat accumulation in the liver, along with at least one of five specified cardiometabolic criteria, while excluding other liver diseases or secondary causes. Osteoporosis is a systemic skeletal condition characterised by reduced bone mass, leading to increased fracture risk. The relationship between MASLD and decrea...